Health Condition 1: C069- Malignant neoplasm of mouth, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with benign or malignant disease of mandible or maxilla who will require free fibular osseocutaneous flap. Consenting to participate in the study and not a part of any other trial or study.
Exclusion criteria
Exclusion criteria: Patients with peripheral vascular disease. Patients who are unfit for surgery (uncontrolled diabetes, severely immunocompromised disease). Evidence of tumour recurrence with bone invasion. Not willing for consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bony union evaluated by NCCT head and neckTimepoint: 6 months postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative time and flap ischemia timeTimepoint: In operation theatre;Postoperative complications including returning to operating room, major bleeding events, venous thromboembolism, flap vascular compromise, flap necrosis, wound dehiscence, infection, bone exposure and orocutaneous fisstula will be assessed.Timepoint: Immediate postoperative period, at 3 and 6 months postoperatively.;Quality of life assessed using EORTC QLQ H&N 35 questionnaireTimepoint: 6 months postoperatively;Mandibular asymmetry and mandibular angle by NCCT headTimepoint: 6 months postoperatively | — |
Countries
India
Contacts
All India Institute of Medical Sciences, Patna